HANSEN GWENN (Chief Scientific Officer) exercised options at NURIX THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/3/2026ACC: 0001817160-26-000004
Officer· Chief Scientific Officer
Since Jul 2020
0.00
Net shares
Net seller
$26.3K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
31.33K acquired · 31.33K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+31.33K
Price / share
$0.84
Trade value
$26.32K
% of position
37.4%
2/3/2026
83.67K→115K
Total
Net shares
+31.33K
Net value
$26.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2026 | M · Option Exercise | +31.33K | $0.84 | $26.32K | 37.4% | 83.67K | 115K |
| Total | +31.33K | $26.32K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
31.33K shares
Shares
−31.33K
Strike price
0.84
Held after
0.00
Exercisable
—
2/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock31.33K shares | 2/3/2026 | M · Option Exercise | −31.33K | 0.84 | — | 0.00 |